Sunday, May 17, 2020

Cipla submits application with USFDA for generic version of asthma drug

Drug major Cipla on Monday said it has submitted an application with
the US health regulator for a generic version of GSK's Advair Diskus,
which is used in the treatment of asthma and other respiratory
disorders.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cipla-submits-application-with-usfda-for-generic-version-of-asthma-drug/articleshow/75798947.cms

No comments:

Post a Comment